187 related articles for article (PubMed ID: 12423447)
1. Review article: albumin in the treatment of liver diseases--new features of a classical treatment.
Arroyo V
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():1-5. PubMed ID: 12423447
[TBL] [Abstract][Full Text] [Related]
2. Review article: albumin for circulatory support in patients with cirrhosis.
Ginès P; Guevara M; De Las Heras D; Arroyo V
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():24-31. PubMed ID: 12423450
[TBL] [Abstract][Full Text] [Related]
3. Albumin in chronic liver disease: structure, functions and therapeutic implications.
Spinella R; Sawhney R; Jalan R
Hepatol Int; 2016 Jan; 10(1):124-32. PubMed ID: 26420218
[TBL] [Abstract][Full Text] [Related]
4. The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Longo N; Panella C; Ierardi E
Curr Drug Saf; 2011 Sep; 6(4):267-74. PubMed ID: 22129322
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of cirrhotic complications with human serum albumin].
Henriksen JH; Ring-Larsen H
Ugeskr Laeger; 2005 Jan; 167(4):414. PubMed ID: 15719571
[No Abstract] [Full Text] [Related]
6. Clinical indications for the albumin use: still a controversial issue.
Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
[TBL] [Abstract][Full Text] [Related]
7. Albumin for end-stage liver disease.
Lee JS
Korean J Intern Med; 2012 Mar; 27(1):13-9. PubMed ID: 22403494
[TBL] [Abstract][Full Text] [Related]
8. Is there still a need for albumin infusions to treat patients with liver disease?
Ginès P; Arroyo V
Gut; 2000 May; 46(5):588-90. PubMed ID: 10764695
[No Abstract] [Full Text] [Related]
9. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
10. Large-volume paracentesis and volume re-expansion: can synthetic plasma expanders safely replace albumin?
Salerno F
J Hepatol; 1992 Mar; 14(2-3):143-5. PubMed ID: 1500676
[No Abstract] [Full Text] [Related]
11. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
12. [The use of albumin infusion in decompensated liver cirrhosis].
Schmidt LE; Ring-Larsen H
Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
[TBL] [Abstract][Full Text] [Related]
14. Review article: volume expansion in patients with cirrhosis.
Henriksen JH; Kiszka-Kanowitz M; Bendtsen F
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():12-23. PubMed ID: 12423449
[TBL] [Abstract][Full Text] [Related]
15. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
Fernández J; Monteagudo J; Bargallo X; Jiménez W; Bosch J; Arroyo V; Navasa M
Hepatology; 2005 Sep; 42(3):627-34. PubMed ID: 16108036
[TBL] [Abstract][Full Text] [Related]
16. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Bertino G; Privitera G; Purrello F; Demma S; Crisafulli E; Spadaro L; Koukias N; Tsochatzis EA
Intern Emerg Med; 2016 Oct; 11(7):905-16. PubMed ID: 27273018
[TBL] [Abstract][Full Text] [Related]
17. [News for usage of albumin in patients with liver disease].
Cremonese C; Uschner FE; Trebicka J
Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
[TBL] [Abstract][Full Text] [Related]
18. Human serum albumin, systemic inflammation, and cirrhosis.
Arroyo V; García-Martinez R; Salvatella X
J Hepatol; 2014 Aug; 61(2):396-407. PubMed ID: 24751830
[TBL] [Abstract][Full Text] [Related]
19. [Resuscitation possibilities in hepatorenal syndrome].
Gessa M; Bertino R; Perani R; Verdecchia C; Rufinelli AR; Capra S; Zaffiri O
Minerva Anestesiol; 1978 Nov; 44(11):847-60. PubMed ID: 112505
[No Abstract] [Full Text] [Related]
20. AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.
Caraceni P; Angeli P; Prati D; Bernardi M; ; Liumbruno GM; Bennardello F; Piccoli P; Velati C;
Blood Transfus; 2016 Jan; 14(1):8-22. PubMed ID: 26820615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
